Keio University

Heartseed Gets $55m Up Front Japanese bioventure Heartseed Inc. and Novo Nordisk A/S announced a worldwide collaboration and license agreement on 1 June for the development, manufacture and commer

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements and collaborations between companies and academic or other research inst

AN2 Launches With $12m In Series A Funding AN2 Therapeutics Inc. launched with $12m in series A financing led by Mountain Group Partners, which was joined by Adjuvant Capital, partner Brii Bioscien

Two new private equity funds will make $1.4bn available to health care investment opportunities: London’s Global Health Opportunities, otherwise known as GHO Capital Partners LP, raised €975m ($1.08bn